| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyBiologicalProcess | positive regulation of mRNA splicing, via spliceosome | 3.14e-08 | 44 | 88 | 6 | GO:0048026 | |
| GeneOntologyBiologicalProcess | positive regulation of mRNA processing | 6.12e-08 | 49 | 88 | 6 | GO:0050685 | |
| GeneOntologyBiologicalProcess | positive regulation of RNA splicing | 2.84e-07 | 63 | 88 | 6 | GO:0033120 | |
| GeneOntologyBiologicalProcess | mRNA splicing, via spliceosome | FMR1 RBMY1A1 RBMY1C RBMY1F RBMY1D RBMY1B RBMY1E RBM6 CWC25 HNRNPF DHX9 | 3.59e-07 | 358 | 88 | 11 | GO:0000398 |
| GeneOntologyBiologicalProcess | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile | FMR1 RBMY1A1 RBMY1C RBMY1F RBMY1D RBMY1B RBMY1E RBM6 CWC25 HNRNPF DHX9 | 3.59e-07 | 358 | 88 | 11 | GO:0000377 |
| GeneOntologyBiologicalProcess | regulation of mRNA processing | 3.80e-07 | 158 | 88 | 8 | GO:0050684 | |
| GeneOntologyBiologicalProcess | RNA splicing, via transesterification reactions | FMR1 RBMY1A1 RBMY1C RBMY1F RBMY1D RBMY1B RBMY1E RBM6 CWC25 HNRNPF DHX9 | 4.00e-07 | 362 | 88 | 11 | GO:0000375 |
| GeneOntologyBiologicalProcess | mRNA processing | SRRT FMR1 CPSF6 RBMY1A1 RBMY1C RBMY1F RBMY1D RBMY1B RBMY1E RBM6 CWC25 HNRNPF DHX9 | 5.89e-07 | 551 | 88 | 13 | GO:0006397 |
| GeneOntologyBiologicalProcess | regulation of mRNA splicing, via spliceosome | 1.32e-06 | 129 | 88 | 7 | GO:0048024 | |
| GeneOntologyBiologicalProcess | mRNA metabolic process | SRRT GSPT2 FMR1 AGO3 CPSF6 RBMY1A1 RBMY1C RBMY1F RBMY1D RBMY1B RBMY1E RBM6 PNRC2 CWC25 HNRNPF DHX9 | 1.46e-06 | 917 | 88 | 16 | GO:0016071 |
| GeneOntologyBiologicalProcess | regulation of RNA splicing | 2.90e-06 | 207 | 88 | 8 | GO:0043484 | |
| GeneOntologyBiologicalProcess | RNA splicing | FMR1 RBMY1A1 RBMY1C RBMY1F RBMY1D RBMY1B RBMY1E RBM6 CWC25 HNRNPF DHX9 | 9.40e-06 | 502 | 88 | 11 | GO:0008380 |
| GeneOntologyBiologicalProcess | positive regulation of mRNA metabolic process | 1.50e-05 | 259 | 88 | 8 | GO:1903313 | |
| GeneOntologyBiologicalProcess | RNA processing | USP36 SRRT RPL7L1 FMR1 AGO3 CPSF6 RBMY1A1 RBMY1C RBMY1F RBMY1D RBMY1B RBMY1E RBM6 TRMT1 CWC25 DDX21 HNRNPF DHX9 | 5.28e-05 | 1500 | 88 | 18 | GO:0006396 |
| GeneOntologyBiologicalProcess | regulation of mRNA metabolic process | 1.14e-04 | 443 | 88 | 9 | GO:1903311 | |
| GeneOntologyBiologicalProcess | positive regulation of RNA export from nucleus | 1.78e-04 | 5 | 88 | 2 | GO:0046833 | |
| GeneOntologyBiologicalProcess | positive regulation of nucleobase-containing compound transport | 2.67e-04 | 6 | 88 | 2 | GO:0032241 | |
| GeneOntologyBiologicalProcess | regulation of transcription by RNA polymerase III | 3.40e-04 | 32 | 88 | 3 | GO:0006359 | |
| GeneOntologyCellularComponent | nuclear protein-containing complex | BCLAF3 BCL9L ARID1B KASH5 SETD5 CPSF6 CSNK2A2 RBMY1A1 RBMY1C RBMY1F RBMY1D RBMY1B RBMY1E MCM3 CHD3 CWC25 DDX21 HNRNPF STAT6 | 2.99e-06 | 1377 | 87 | 19 | GO:0140513 |
| GeneOntologyCellularComponent | spliceosomal complex | 3.20e-06 | 215 | 87 | 8 | GO:0005681 | |
| GeneOntologyCellularComponent | ribonucleoprotein complex | SRRT RPL7L1 FMR1 AGO3 CPSF6 RBMY1A1 RBMY1C RBMY1F RBMY1D RBMY1B RBMY1E CWC25 HNRNPF DHX9 | 3.94e-04 | 1194 | 87 | 14 | GO:1990904 |
| GeneOntologyCellularComponent | male germ cell nucleus | 4.58e-04 | 86 | 87 | 4 | GO:0001673 | |
| GeneOntologyCellularComponent | perichromatin fibrils | 4.72e-04 | 8 | 87 | 2 | GO:0005726 | |
| GeneOntologyCellularComponent | nuclear chromosome | 6.74e-04 | 254 | 87 | 6 | GO:0000228 | |
| GeneOntologyCellularComponent | RISC-loading complex | 7.54e-04 | 10 | 87 | 2 | GO:0070578 | |
| GeneOntologyCellularComponent | insulin-responsive compartment | 9.19e-04 | 11 | 87 | 2 | GO:0032593 | |
| GeneOntologyCellularComponent | germ cell nucleus | 1.28e-03 | 113 | 87 | 4 | GO:0043073 | |
| Domain | RBM1CTR | 1.02e-10 | 8 | 86 | 5 | PF08081 | |
| Domain | RBM1CTR | 1.02e-10 | 8 | 86 | 5 | IPR012604 | |
| Domain | Nucleotide-bd_a/b_plait | SRRT CPSF6 RBMY1A1 RBMY1F RBMY1D RBMY1B RBMY1E RBM6 DDX21 HNRNPF | 2.99e-07 | 258 | 86 | 10 | IPR012677 |
| Domain | RRM | 7.12e-06 | 217 | 86 | 8 | SM00360 | |
| Domain | RRM_dom | 9.89e-06 | 227 | 86 | 8 | IPR000504 | |
| Domain | RRM | 1.09e-05 | 230 | 86 | 8 | PS50102 | |
| Domain | RRM_1 | 4.90e-05 | 208 | 86 | 7 | PF00076 | |
| Domain | K_chnl_volt-dep_Kv6 | 6.27e-05 | 3 | 86 | 2 | IPR003969 | |
| Domain | - | 1.33e-04 | 244 | 86 | 7 | 3.30.70.330 | |
| Pathway | REACTOME_CYTOSOLIC_SENSORS_OF_PATHOGEN_ASSOCIATED_DNA | 1.43e-05 | 32 | 66 | 4 | MM14707 | |
| Pubmed | 1.65e-15 | 7 | 89 | 6 | 8269511 | ||
| Pubmed | 2.16e-13 | 12 | 89 | 6 | 9598316 | ||
| Pubmed | 5.86e-13 | 6 | 89 | 5 | 15184870 | ||
| Pubmed | Degeneracy in human multicopy RBM (YRRM), a candidate spermatogenesis gene. | 2.05e-12 | 7 | 89 | 5 | 8875892 | |
| Pubmed | An RBM homologue maps to the mouse Y chromosome and is expressed in germ cells. | 2.00e-10 | 5 | 89 | 4 | 8817321 | |
| Pubmed | 2.00e-10 | 5 | 89 | 4 | 20016065 | ||
| Pubmed | The role of human and mouse Y chromosome genes in male infertility. | 2.00e-10 | 5 | 89 | 4 | 11097427 | |
| Pubmed | Rapid evolution of mouse Y centromere repeat DNA belies recent sequence stability. | 2.00e-10 | 5 | 89 | 4 | 19737860 | |
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | USP36 SRRT FLNC RPL7L1 CPSF6 ACLY CSNK2A2 DNAJA2 YLPM1 RBM6 TRMT1 MCM3 DDX21 HNRNPF ATP5F1B YARS2 DHX9 | 5.04e-10 | 989 | 89 | 17 | 36424410 |
| Pubmed | 5.99e-10 | 6 | 89 | 4 | 18239052 | ||
| Pubmed | Identification of target messenger RNA substrates for mouse RBMY. | 5.99e-10 | 6 | 89 | 4 | 18492746 | |
| Pubmed | Meiotic sex chromosome inactivation in male mice with targeted disruptions of Xist. | 5.99e-10 | 6 | 89 | 4 | 12356914 | |
| Pubmed | 5.99e-10 | 6 | 89 | 4 | 9499427 | ||
| Pubmed | 5.99e-10 | 6 | 89 | 4 | 15051956 | ||
| Pubmed | 1.39e-09 | 7 | 89 | 4 | 17001072 | ||
| Pubmed | The roles of RNA-binding proteins in spermatogenesis and male infertility. | 1.39e-09 | 7 | 89 | 4 | 10377282 | |
| Pubmed | SRRT FLNC ARHGAP32 FMR1 CPSF6 ACLY CSNK2A2 DNAJA2 MCM3 DDX21 HNRNPF ATP5F1B DHX9 | 1.61e-09 | 551 | 89 | 13 | 34728620 | |
| Pubmed | 2.78e-09 | 8 | 89 | 4 | 7479793 | ||
| Pubmed | 8.31e-09 | 10 | 89 | 4 | 10601091 | ||
| Pubmed | 8.31e-09 | 10 | 89 | 4 | 9384609 | ||
| Pubmed | The role of Dby mRNA in early development of male mouse zygotes. | 1.95e-08 | 12 | 89 | 4 | 20543856 | |
| Pubmed | GASZ promotes germ cell derivation from embryonic stem cells. | 2.81e-08 | 13 | 89 | 4 | 23816659 | |
| Pubmed | 2.81e-08 | 13 | 89 | 4 | 10749975 | ||
| Pubmed | Absence of mDazl produces a final block on germ cell development at meiosis. | 3.93e-08 | 14 | 89 | 4 | 14611631 | |
| Pubmed | Evolutionary strata on the mouse X chromosome correspond to strata on the human X chromosome. | 5.35e-08 | 15 | 89 | 4 | 14762062 | |
| Pubmed | TNIP2 is a Hub Protein in the NF-κB Network with Both Protein and RNA Mediated Interactions. | GPC1 SRRT MBTPS1 ARID1B FMR1 CPSF6 ACLY DNAJA2 NFKBIB YLPM1 MCM3 HNRNPF ATP5F1B DHX9 | 9.28e-08 | 922 | 89 | 14 | 27609421 |
| Pubmed | Loss of maternal Trim28 causes male-predominant early embryonic lethality. | 9.29e-08 | 17 | 89 | 4 | 28115466 | |
| Pubmed | TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation. | 1.03e-07 | 220 | 89 | 8 | 35785414 | |
| Pubmed | The PRMT5/WDR77 complex regulates alternative splicing through ZNF326 in breast cancer. | 1.08e-07 | 147 | 89 | 7 | 28977470 | |
| Pubmed | Sex differences in sex chromosome gene expression in mouse brain. | 1.19e-07 | 18 | 89 | 4 | 12023983 | |
| Pubmed | 2.79e-07 | 347 | 89 | 9 | 16033648 | ||
| Pubmed | Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation. | 2.80e-07 | 457 | 89 | 10 | 32344865 | |
| Pubmed | Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15. | SRRT FMR1 CPSF6 ACLY RBM6 MCM3 CHD3 DDX21 SEZ6L2 HNRNPF ATP5F1B DHX9 | 2.87e-07 | 714 | 89 | 12 | 28302793 |
| Pubmed | 5.70e-07 | 494 | 89 | 10 | 26831064 | ||
| Pubmed | 5.74e-07 | 26 | 89 | 4 | 35920200 | ||
| Pubmed | GPC1 SRRT TGM1 FLNC ARHGAP32 FMR1 ACLY CSNK2A2 DNAJA2 MINK1 DGKB CHD3 HNRNPF ATP5F1B DHX9 SLC12A5 | 6.43e-07 | 1431 | 89 | 16 | 37142655 | |
| Pubmed | CPSF6 DNAJA2 DDR2 TENM1 ADAMTS20 MCM3 DDX21 HNRNPF ATP5F1B DHX9 | 8.02e-07 | 513 | 89 | 10 | 25798074 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | USP36 SRRT ARID1B CPSF6 YLPM1 RBM6 MCM3 CHD3 CWC25 DDX21 HNRNPF ATP5F1B DHX9 | 9.42e-07 | 954 | 89 | 13 | 36373674 |
| Pubmed | GPC1 SRRT FMR1 ACLY CSNK2A2 DNAJA2 YLPM1 MCM3 DDX21 HNRNPF DHX9 | 1.01e-06 | 660 | 89 | 11 | 32780723 | |
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | SRRT RPL7L1 GSPT2 FMR1 AGO3 CPSF6 YLPM1 RBM6 DDX21 HNRNPF YARS2 DHX9 | 1.04e-06 | 807 | 89 | 12 | 22681889 |
| Pubmed | 1.39e-06 | 421 | 89 | 9 | 34650049 | ||
| Pubmed | 1.63e-06 | 220 | 89 | 7 | 24550385 | ||
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | 1.99e-06 | 440 | 89 | 9 | 34244565 | |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | SRRT GSPT2 CPSF6 ACLY CSNK2A2 DNAJA2 TRMT1 MCM3 SEC31A ZNF593 DDX21 HNRNPF ATP5F1B YARS2 DHX9 | 2.90e-06 | 1415 | 89 | 15 | 28515276 |
| Pubmed | RUFY1 binds Arl8b and mediates endosome-to-TGN CI-M6PR retrieval for cargo sorting to lysosomes. | 2.97e-06 | 344 | 89 | 8 | 36282215 | |
| Pubmed | 3.01e-06 | 463 | 89 | 9 | 34901782 | ||
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | USP36 SRRT RPL7L1 FMR1 CPSF6 ACLY CSNK2A2 DNAJA2 MCM3 SEC31A DDX21 HNRNPF ATP5F1B YARS2 DHX9 | 3.16e-06 | 1425 | 89 | 15 | 30948266 |
| Pubmed | DBIRD complex integrates alternative mRNA splicing with RNA polymerase II transcript elongation. | 3.43e-06 | 89 | 89 | 5 | 22446626 | |
| Pubmed | CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality. | 3.49e-06 | 605 | 89 | 10 | 28977666 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | SRRT ACLY CSNK2A2 MINK1 YLPM1 RBM6 MCM3 CHD3 DDX21 HNRNPF DHX9 | 4.67e-06 | 774 | 89 | 11 | 15302935 |
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | GPC1 TGM1 RPL7L1 GSPT2 FMR1 CPSF6 ACLY MCM3 ZNF593 DDX21 HNRNPF DHX9 | 5.49e-06 | 949 | 89 | 12 | 36574265 |
| Pubmed | 5.55e-06 | 172 | 89 | 6 | 26336360 | ||
| Pubmed | Human BRE1 is an E3 ubiquitin ligase for Ebp1 tumor suppressor. | 5.78e-06 | 14 | 89 | 3 | 19037095 | |
| Pubmed | 5.80e-06 | 641 | 89 | 10 | 36057605 | ||
| Pubmed | Potential dual functional roles of the Y-linked RBMY in hepatocarcinogenesis. | 6.48e-06 | 2 | 89 | 2 | 32473614 | |
| Pubmed | 6.48e-06 | 2 | 89 | 2 | 17237818 | ||
| Pubmed | Complex interplay between FMRP and DHX9 during DNA replication stress. | 6.48e-06 | 2 | 89 | 2 | 38110032 | |
| Pubmed | 6.82e-06 | 653 | 89 | 10 | 33742100 | ||
| Pubmed | 6.93e-06 | 274 | 89 | 7 | 34244482 | ||
| Pubmed | An inducible CRISPR/Cas9 screen identifies DTX2 as a transcriptional regulator of human telomerase. | 7.20e-06 | 180 | 89 | 6 | 35198878 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | GPC1 USP36 SRRT TGM1 FLNC RPL7L1 ACLY DNAJA2 MCM3 SEC31A DDX21 HNRNPF ATP5F1B DHX9 | 8.49e-06 | 1353 | 89 | 14 | 29467282 |
| Pubmed | 8.79e-06 | 399 | 89 | 8 | 35987950 | ||
| Pubmed | 9.87e-06 | 52 | 89 | 4 | 26265008 | ||
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | SRRT FLNC RPL7L1 CPSF6 ACLY YLPM1 MCM3 CHD3 DDX21 HNRNPF ATP5F1B DHX9 | 1.18e-05 | 1024 | 89 | 12 | 24711643 |
| Pubmed | 1.20e-05 | 197 | 89 | 6 | 31620119 | ||
| Pubmed | Lineage-specific biology revealed by a finished genome assembly of the mouse. | 1.24e-05 | 55 | 89 | 4 | 19468303 | |
| Pubmed | USP36 SRRT RPL7L1 CPSF6 DNAJA2 SEC31A DDX21 HNRNPF ATP5F1B DHX9 | 1.42e-05 | 711 | 89 | 10 | 33022573 | |
| Pubmed | Proteomic and functional analysis of Argonaute-containing mRNA-protein complexes in human cells. | 1.43e-05 | 57 | 89 | 4 | 17932509 | |
| Pubmed | SRRT RPL7L1 FMR1 CPSF6 CSNK2A2 DNAJA2 DDX21 HNRNPF YARS2 DHX9 | 1.46e-05 | 713 | 89 | 10 | 29802200 | |
| Pubmed | 1.64e-05 | 59 | 89 | 4 | 11279525 | ||
| Pubmed | USP36 RPL7L1 GSPT2 CPSF6 RBM6 PARD3B DDX21 HNRNPF ATP5F1B DHX9 | 1.64e-05 | 723 | 89 | 10 | 34133714 | |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | 1.66e-05 | 724 | 89 | 10 | 36232890 | |
| Pubmed | LukS-PV inhibits hepatocellular carcinoma cells migration by downregulating HDAC6 expression. | 1.82e-05 | 580 | 89 | 9 | 35676659 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | GPC1 SRRT RPL7L1 FMR1 CPSF6 ACLY CSNK2A2 DNAJA2 MCM3 DDX21 HNRNPF ATP5F1B DHX9 | 1.85e-05 | 1257 | 89 | 13 | 36526897 |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | GPC1 SRRT FLNC GSPT2 HECTD3 ACLY CSNK2A2 TRMT1 MCM3 SCLY HNRNPF ATP5F1B STAT6 DHX9 | 1.91e-05 | 1455 | 89 | 14 | 22863883 |
| Pubmed | 1.94e-05 | 3 | 89 | 2 | 15145939 | ||
| Pubmed | 1.94e-05 | 3 | 89 | 2 | 34388204 | ||
| Pubmed | 1.94e-05 | 3 | 89 | 2 | 28460433 | ||
| Pubmed | Histone acetyltransferease p300 modulates TIM4 expression in dendritic cells. | 1.94e-05 | 3 | 89 | 2 | 26899911 | |
| Pubmed | Signal transducer and activator of transcription 6 directly regulates human ORMDL3 expression. | 1.94e-05 | 3 | 89 | 2 | 23461825 | |
| Pubmed | 1.94e-05 | 3 | 89 | 2 | 19590752 | ||
| Pubmed | Cooperation of the transcriptional coactivators CBP and p300 with Stat6. | 1.94e-05 | 3 | 89 | 2 | 10454341 | |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | SRRT FLNC ARID1B CPSF6 YLPM1 RBM6 MCM3 SEC31A ZNF593 DDX21 HNRNPF DHX9 | 2.03e-05 | 1082 | 89 | 12 | 38697112 |
| Pubmed | Lysosomal Signaling Licenses Embryonic Stem Cell Differentiation via Inactivation of Tfe3. | 2.39e-05 | 332 | 89 | 7 | 30595499 | |
| Pubmed | Network organization of the huntingtin proteomic interactome in mammalian brain. | RAB4B ACLY CSNK2A2 DNAJA2 MINK1 ADAMTS20 ATP5F1B DHX9 SLC12A5 | 3.11e-05 | 621 | 89 | 9 | 22794259 |
| Pubmed | Poly(ADP-ribosyl)ation of BRD7 by PARP1 confers resistance to DNA-damaging chemotherapeutic agents. | 3.60e-05 | 486 | 89 | 8 | 30940648 | |
| Pubmed | ARID1B RAB4B ACLY CSNK2A2 DNAJA2 CHD3 ZNF593 DDX21 RAB4A HNRNPF ATP5F1B DHX9 | 3.77e-05 | 1153 | 89 | 12 | 29845934 | |
| Pubmed | Ser727-dependent recruitment of MCM5 by Stat1alpha in IFN-gamma-induced transcriptional activation. | 3.87e-05 | 4 | 89 | 2 | 9843502 | |
| Pubmed | Functional cross-talk between Rab14 and Rab4 through a dual effector, RUFY1/Rabip4. | 3.87e-05 | 4 | 89 | 2 | 20534812 | |
| Pubmed | The DEXD/H-box RNA helicase RHII/Gu is a co-factor for c-Jun-activated transcription. | 3.87e-05 | 4 | 89 | 2 | 11823437 | |
| Pubmed | SLFN11 Blocks Stressed Replication Forks Independently of ATR. | 3.87e-05 | 4 | 89 | 2 | 29395061 | |
| Pubmed | 3.87e-05 | 4 | 89 | 2 | 30063986 | ||
| Pubmed | SLC22A18 FMR1 AGO3 BET1 CPSF6 ACLY MCM3 DDX21 HNRNPF CLCC1 ATP5F1B DHX9 | 4.27e-05 | 1168 | 89 | 12 | 19946888 | |
| Pubmed | TRIM65 regulates microRNA activity by ubiquitination of TNRC6. | 4.29e-05 | 364 | 89 | 7 | 24778252 | |
| Pubmed | 4.81e-05 | 657 | 89 | 9 | 36180527 | ||
| Pubmed | 5.07e-05 | 28 | 89 | 3 | 38492217 | ||
| Pubmed | Complementary proteomics strategies capture an ataxin-1 interactome in Neuro-2a cells. | 5.28e-05 | 665 | 89 | 9 | 30457570 | |
| Pubmed | 5.90e-05 | 383 | 89 | 7 | 29331416 | ||
| Pubmed | 6.06e-05 | 844 | 89 | 10 | 25963833 | ||
| Pubmed | 6.44e-05 | 5 | 89 | 2 | 20221248 | ||
| Interaction | RBMX interactions | CPSF6 ACLY RBMY1A1 RBMY1F YLPM1 RBMY1E MCM3 CHD3 DDX21 EP300 HNRNPF YARS2 DHX9 | 8.71e-08 | 461 | 87 | 13 | int:RBMX |
| Interaction | MYCN interactions | USP36 SRRT TGM1 ARID1B RPL7L1 GSPT2 FMR1 AGO3 CPSF6 ACLY CSNK2A2 RBM6 MCM3 EFCC1 SEC31A ZNF593 CWC25 DDX21 EP300 HNRNPF DHX9 | 2.66e-07 | 1373 | 87 | 21 | int:MYCN |
| Interaction | HNRNPD interactions | GPC1 ARHGAP32 DNAH3 FMR1 AGO3 CPSF6 ACLY YLPM1 CHD3 SEC31A DDX21 EP300 HNRNPF DHX9 | 5.65e-07 | 638 | 87 | 14 | int:HNRNPD |
| Interaction | NCBP1 interactions | 2.90e-06 | 353 | 87 | 10 | int:NCBP1 | |
| Interaction | TRIP4 interactions | 3.04e-06 | 206 | 87 | 8 | int:TRIP4 | |
| Interaction | WDR77 interactions | 3.53e-06 | 361 | 87 | 10 | int:WDR77 | |
| Interaction | BMI1 interactions | SRRT TGM1 FBLN5 CSNK2A2 YLPM1 RBM6 CHD3 SEC31A ZNF593 EP300 HNRNPF ATP5F1B YARS2 | 4.81e-06 | 659 | 87 | 13 | int:BMI1 |
| Interaction | OBSL1 interactions | SRRT FLNC ARHGAP32 FBLN5 RPL7L1 CPSF6 ACLY DNAJA2 YLPM1 MCM3 RSPH6A DDX21 HNRNPF ATP5F1B DHX9 | 6.65e-06 | 902 | 87 | 15 | int:OBSL1 |
| Interaction | PRMT1 interactions | SRRT FLNC ARHGAP32 FMR1 CPSF6 ACLY CSNK2A2 DNAJA2 YLPM1 MCM3 DDX21 EP300 HNRNPF ATP5F1B DHX9 | 9.47e-06 | 929 | 87 | 15 | int:PRMT1 |
| Interaction | ERH interactions | 1.09e-05 | 245 | 87 | 8 | int:ERH | |
| Interaction | ETV5 interactions | 1.20e-05 | 33 | 87 | 4 | int:ETV5 | |
| Interaction | ALG13 interactions | 1.44e-05 | 183 | 87 | 7 | int:ALG13 | |
| Interaction | SIRT6 interactions | SRRT ARID1B FMR1 ACLY CSNK2A2 YLPM1 RBM6 MCM3 CHD3 EP300 HNRNPF DHX9 | 1.59e-05 | 628 | 87 | 12 | int:SIRT6 |
| Interaction | HNRNPK interactions | GPC1 SRRT RPL7L1 CPSF6 ACLY RBMY1A1 RBMY1F MCM3 CHD3 DDX21 EP300 HNRNPF YARS2 DHX9 | 1.63e-05 | 853 | 87 | 14 | int:HNRNPK |
| Interaction | SUPT16H interactions | 2.06e-05 | 442 | 87 | 10 | int:SUPT16H | |
| Interaction | DHX9 interactions | USP36 SRRT FMR1 CPSF6 DDR2 CHD3 DDX21 EP300 HNRNPF ATP5F1B STAT6 DHX9 | 2.66e-05 | 662 | 87 | 12 | int:DHX9 |
| Interaction | KIF23 interactions | SRRT FMR1 AGO3 ACLY CSNK2A2 DNAJA2 MINK1 MCM3 CHD3 SEC31A DDX21 HNRNPF ATP5F1B YARS2 DHX9 | 3.21e-05 | 1031 | 87 | 15 | int:KIF23 |
| Interaction | NUPR1 interactions | GPC1 SRRT FMR1 ACLY CSNK2A2 DNAJA2 YLPM1 MCM3 DDX21 EP300 HNRNPF DHX9 | 3.61e-05 | 683 | 87 | 12 | int:NUPR1 |
| Interaction | RBM39 interactions | SRRT FMR1 CPSF6 ACLY CSNK2A2 YLPM1 RBM6 MCM3 CHD3 DDX21 SEZ6L2 EP300 HNRNPF ATP5F1B DHX9 | 3.63e-05 | 1042 | 87 | 15 | int:RBM39 |
| Interaction | PLRG1 interactions | 4.17e-05 | 216 | 87 | 7 | int:PLRG1 | |
| Interaction | DNAJC9 interactions | 4.22e-05 | 296 | 87 | 8 | int:DNAJC9 | |
| Interaction | TRA2B interactions | 4.26e-05 | 385 | 87 | 9 | int:TRA2B | |
| Interaction | PPP1CA interactions | BCL9L FBLN5 FMR1 CPSF6 ACLY YLPM1 TRMT1 MCM3 CHD3 SEC31A EP300 HNRNPF | 4.34e-05 | 696 | 87 | 12 | int:PPP1CA |
| Interaction | ZFR interactions | 4.74e-05 | 301 | 87 | 8 | int:ZFR | |
| Interaction | SRSF9 interactions | 5.25e-05 | 224 | 87 | 7 | int:SRSF9 | |
| Interaction | HNRNPF interactions | USP36 ERBB3 CPSF6 ACLY CSNK2A2 BBS2 MCM3 CHD3 EP300 HNRNPF DHX9 | 5.95e-05 | 607 | 87 | 11 | int:HNRNPF |
| Interaction | GLDC interactions | 7.45e-05 | 321 | 87 | 8 | int:GLDC | |
| Interaction | SMC5 interactions | USP36 SRRT RADIL ARID1B CPSF6 YLPM1 RBM6 MCM3 CHD3 CWC25 DDX21 HNRNPF ATP5F1B DHX9 | 9.17e-05 | 1000 | 87 | 14 | int:SMC5 |
| Interaction | RBMY1E interactions | 1.10e-04 | 4 | 87 | 2 | int:RBMY1E | |
| Interaction | SRRT interactions | 1.11e-04 | 340 | 87 | 8 | int:SRRT | |
| Interaction | SNAI1 interactions | USP36 CPSF6 ACLY MCM3 DDX21 QRICH2 EP300 HNRNPF ATP5F1B DHX9 | 1.21e-04 | 546 | 87 | 10 | int:SNAI1 |
| Interaction | THRAP3 interactions | 1.24e-04 | 443 | 87 | 9 | int:THRAP3 | |
| Interaction | AIMP2 interactions | 1.31e-04 | 446 | 87 | 9 | int:AIMP2 | |
| Interaction | FAM120A interactions | 1.33e-04 | 349 | 87 | 8 | int:FAM120A | |
| Interaction | MTREX interactions | 1.40e-04 | 262 | 87 | 7 | int:MTREX | |
| Interaction | TRIM31 interactions | 1.50e-04 | 454 | 87 | 9 | int:TRIM31 | |
| Interaction | DDX5 interactions | 1.67e-04 | 568 | 87 | 10 | int:DDX5 | |
| Interaction | SSRP1 interactions | USP36 SRRT SETD5 CSNK2A2 YLPM1 MCM3 CHD3 DDX21 APLF EP300 DHX9 | 1.73e-04 | 685 | 87 | 11 | int:SSRP1 |
| Interaction | ZBTB7B interactions | 1.84e-04 | 366 | 87 | 8 | int:ZBTB7B | |
| Interaction | CHD4 interactions | USP36 SRRT FMR1 INSYN1 CSNK2A2 YLPM1 MCM3 CHD3 DDX21 EP300 HNRNPF ATP5F1B DHX9 | 1.85e-04 | 938 | 87 | 13 | int:CHD4 |
| Interaction | RBM28 interactions | 1.91e-04 | 368 | 87 | 8 | int:RBM28 | |
| Interaction | CNBP interactions | 1.92e-04 | 276 | 87 | 7 | int:CNBP | |
| Interaction | TOP1 interactions | USP36 SRRT CPSF6 CSNK2A2 YLPM1 RBM6 MCM3 CHD3 DDX21 APLF DHX9 | 1.99e-04 | 696 | 87 | 11 | int:TOP1 |
| Interaction | NEK4 interactions | CPSF6 DNAJA2 DDR2 TENM1 ADAMTS20 MCM3 DDX21 HNRNPF ATP5F1B DHX9 | 2.03e-04 | 582 | 87 | 10 | int:NEK4 |
| Interaction | LYAR interactions | 2.09e-04 | 373 | 87 | 8 | int:LYAR | |
| Interaction | TNIP2 interactions | SRRT MBTPS1 ARID1B FMR1 CPSF6 ACLY DNAJA2 YLPM1 MCM3 EP300 HNRNPF ATP5F1B DHX9 | 2.14e-04 | 952 | 87 | 13 | int:TNIP2 |
| Interaction | ADAR interactions | 2.39e-04 | 286 | 87 | 7 | int:ADAR | |
| Interaction | WDR5 interactions | USP36 SRRT RPL7L1 CPSF6 ACLY CSNK2A2 DNAJA2 CHD3 SEC31A DDX21 EP300 HNRNPF ATP5F1B DHX9 | 2.50e-04 | 1101 | 87 | 14 | int:WDR5 |
| Interaction | SNRPF interactions | 2.59e-04 | 385 | 87 | 8 | int:SNRPF | |
| Interaction | RBMY1J interactions | 2.62e-04 | 29 | 87 | 3 | int:RBMY1J | |
| Interaction | CUL7 interactions | SRRT ARHGAP32 FBLN5 RPL7L1 AGO3 CPSF6 ACLY RBM6 DDX21 HNRNPF ATP5F1B DHX9 | 2.69e-04 | 845 | 87 | 12 | int:CUL7 |
| Interaction | SUGP2 interactions | 2.76e-04 | 207 | 87 | 6 | int:SUGP2 | |
| Interaction | KCTD13 interactions | GPC1 SRRT TGM1 FLNC ARHGAP32 FMR1 ACLY CSNK2A2 DNAJA2 MINK1 DGKB CHD3 HNRNPF ATP5F1B DHX9 SLC12A5 | 2.77e-04 | 1394 | 87 | 16 | int:KCTD13 |
| Interaction | PCGF1 interactions | 2.83e-04 | 208 | 87 | 6 | int:PCGF1 | |
| Interaction | CDC5L interactions | FMR1 CPSF6 CSNK2A2 YLPM1 RBM6 MCM3 CHD3 CWC25 DDX21 EP300 HNRNPF DHX9 | 2.99e-04 | 855 | 87 | 12 | int:CDC5L |
| Interaction | CHTOP interactions | 3.14e-04 | 212 | 87 | 6 | int:CHTOP | |
| Interaction | AR interactions | BCL9L SRRT ARID1B CPSF6 ACLY YLPM1 MCM3 PNRC2 CHD3 EP300 HNRNPF ATP5F1B DHX9 | 3.19e-04 | 992 | 87 | 13 | int:AR |
| Interaction | ATAD3B interactions | 3.22e-04 | 213 | 87 | 6 | int:ATAD3B | |
| Interaction | MTDH interactions | 3.29e-04 | 505 | 87 | 9 | int:MTDH | |
| Interaction | INPPL1 interactions | 3.30e-04 | 214 | 87 | 6 | int:INPPL1 | |
| Interaction | TXNL4A interactions | 3.45e-04 | 77 | 87 | 4 | int:TXNL4A | |
| Interaction | SP7 interactions | 3.46e-04 | 304 | 87 | 7 | int:SP7 | |
| Interaction | SNRPB interactions | 3.90e-04 | 517 | 87 | 9 | int:SNRPB | |
| Interaction | GATA4 interactions | 4.01e-04 | 411 | 87 | 8 | int:GATA4 | |
| Interaction | CHD3 interactions | USP36 SRRT FMR1 YLPM1 MCM3 CHD3 DDX21 EP300 HNRNPF ATP5F1B DHX9 | 4.07e-04 | 757 | 87 | 11 | int:CHD3 |
| Interaction | HDAC3 interactions | 4.12e-04 | 313 | 87 | 7 | int:HDAC3 | |
| Interaction | BRD7 interactions | ARID1B RPL7L1 FMR1 CPSF6 DNAJA2 MCM3 DDX21 EP300 HNRNPF DHX9 | 4.16e-04 | 637 | 87 | 10 | int:BRD7 |
| Interaction | ALYREF interactions | 4.34e-04 | 416 | 87 | 8 | int:ALYREF | |
| Interaction | ILF3 interactions | GPC1 USP36 RPL7L1 FMR1 CPSF6 YLPM1 RBM6 CHD3 DDX21 EP300 ATP5F1B DHX9 | 4.56e-04 | 896 | 87 | 12 | int:ILF3 |
| Interaction | SMG7 interactions | 4.61e-04 | 319 | 87 | 7 | int:SMG7 | |
| Interaction | ANKRD55 interactions | 4.62e-04 | 228 | 87 | 6 | int:ANKRD55 | |
| Interaction | NUP35 interactions | 4.92e-04 | 424 | 87 | 8 | int:NUP35 | |
| Interaction | PRPF8 interactions | USP36 INSYN1 CPSF6 DNAJA2 RBM6 CHD3 DDX21 EP300 HNRNPF ATP5F1B DHX9 | 5.00e-04 | 776 | 87 | 11 | int:PRPF8 |
| Interaction | RBMY1F interactions | 5.01e-04 | 36 | 87 | 3 | int:RBMY1F | |
| Interaction | MIR17 interactions | 5.03e-04 | 85 | 87 | 4 | int:MIR17 | |
| Interaction | SURF6 interactions | 5.08e-04 | 426 | 87 | 8 | int:SURF6 | |
| Interaction | ZNF746 interactions | 5.25e-04 | 326 | 87 | 7 | int:ZNF746 | |
| Interaction | KLF1 interactions | 5.43e-04 | 37 | 87 | 3 | int:KLF1 | |
| Interaction | ZCCHC8 interactions | 5.45e-04 | 154 | 87 | 5 | int:ZCCHC8 | |
| Interaction | MIR29A interactions | 5.49e-04 | 87 | 87 | 4 | int:MIR29A | |
| Interaction | KIF20A interactions | FLNC RPL7L1 FMR1 AGO3 INSYN1 DNAJA2 MINK1 YLPM1 MCM3 DDX21 HNRNPF ATP5F1B DHX9 | 5.58e-04 | 1052 | 87 | 13 | int:KIF20A |
| Interaction | MIR138-2 interactions | 5.73e-04 | 88 | 87 | 4 | int:MIR138-2 | |
| Interaction | RBM42 interactions | 5.75e-04 | 331 | 87 | 7 | int:RBM42 | |
| Interaction | NCBP3 interactions | 5.78e-04 | 156 | 87 | 5 | int:NCBP3 | |
| Interaction | SEC23IP interactions | 6.19e-04 | 241 | 87 | 6 | int:SEC23IP | |
| Interaction | XRCC6 interactions | USP36 TGM1 CPSF6 DNAJA2 YLPM1 PNRC2 CHD3 DDX21 APLF EP300 ATP5F1B DHX9 | 6.23e-04 | 928 | 87 | 12 | int:XRCC6 |
| Interaction | HDAC6 interactions | GPC1 ERBB3 GSPT2 ACLY CSNK2A2 DNAJA2 MCM3 DDX21 EP300 HNRNPF ATP5F1B DHX9 | 6.29e-04 | 929 | 87 | 12 | int:HDAC6 |
| Interaction | RBM14 interactions | 6.34e-04 | 553 | 87 | 9 | int:RBM14 | |
| Interaction | YLPM1 interactions | 6.48e-04 | 160 | 87 | 5 | int:YLPM1 | |
| Interaction | HOXB3 interactions | 6.50e-04 | 9 | 87 | 2 | int:HOXB3 | |
| Interaction | TAAR3P interactions | 6.50e-04 | 9 | 87 | 2 | int:TAAR3P | |
| Interaction | GTPBP4 interactions | 6.56e-04 | 443 | 87 | 8 | int:GTPBP4 | |
| Interaction | SAFB interactions | 6.60e-04 | 244 | 87 | 6 | int:SAFB | |
| Interaction | NKRF interactions | 6.60e-04 | 244 | 87 | 6 | int:NKRF | |
| Interaction | TERF2 interactions | 6.73e-04 | 340 | 87 | 7 | int:TERF2 | |
| Interaction | METTL14 interactions | 6.76e-04 | 558 | 87 | 9 | int:METTL14 | |
| Interaction | MIR128-1 interactions | 6.78e-04 | 92 | 87 | 4 | int:MIR128-1 | |
| Interaction | NAGK interactions | 6.86e-04 | 162 | 87 | 5 | int:NAGK | |
| Interaction | PRPF40A interactions | 6.86e-04 | 446 | 87 | 8 | int:PRPF40A | |
| Interaction | MCM2 interactions | SRRT TGM1 FLNC HMCN1 ACLY DNAJA2 MCM3 CHD3 DDX21 EP300 HNRNPF ATP5F1B DHX9 | 7.19e-04 | 1081 | 87 | 13 | int:MCM2 |
| Cytoband | Yq11.223 | 1.11e-06 | 93 | 89 | 5 | Yq11.223 | |
| Cytoband | Xp22.12 | 1.03e-04 | 8 | 89 | 2 | Xp22.12 | |
| Cytoband | 1p36.11 | 3.22e-04 | 68 | 89 | 3 | 1p36.11 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chrYq11 | 3.60e-04 | 311 | 89 | 5 | chrYq11 | |
| GeneFamily | RNA binding motif containing | CPSF6 RBMY1A1 RBMY1C RBMY1F RBMY1D RBMY1B RBMY1E RBM6 HNRNPF | 5.80e-08 | 213 | 64 | 9 | 725 |
| GeneFamily | Fibulins | 3.41e-04 | 8 | 64 | 2 | 556 | |
| Coexpression | CHEN_ETV5_TARGETS_TESTIS | 4.51e-06 | 33 | 88 | 4 | MM701 | |
| Coexpression | ZHENG_IL22_SIGNALING_DN | 1.59e-05 | 45 | 88 | 4 | MM763 | |
| Coexpression | GSE15624_3H_VS_6H_HALOFUGINONE_TREATED_CD4_TCELL_UP | 2.46e-05 | 171 | 88 | 6 | M7105 | |
| Coexpression | THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_RESPONDERS_28DY_DN | USP36 SRRT SLC22A18 UBXN11 RPL7L1 MEGF6 POLG OSBPL7 TRMT1 CWC25 EP300 STAT6 | 4.92e-05 | 905 | 88 | 12 | M40865 |
| Coexpression | THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_RESPONDERS_7DY_DN | USP36 SRRT SLC22A18 UBXN11 POLG OSBPL7 TRMT1 CWC25 EP300 STAT6 | 5.29e-05 | 634 | 88 | 10 | M40866 |
| ToppCell | droplet-Heart-HEART-1m-Endothelial-endocardial_endothelial_cells|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.92e-06 | 191 | 86 | 6 | 4bfdf44d4402a42530d30c89d94946acdda4321b | |
| ToppCell | droplet-Heart-HEART-1m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.04e-06 | 193 | 86 | 6 | d0a5f212f8e8a13dbbe3e41df92548ef82eef70b | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.04e-06 | 193 | 86 | 6 | b3ad5ff480d99217f36cc7471e5a96a519ddb409 | |
| ToppCell | facs-Heart-RA-24m-Endothelial-endothelial_cell_of_endocardium|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.21e-05 | 174 | 86 | 5 | 42dfb6f42b72e40e203b3ef341117bccf3553d54 | |
| ToppCell | facs-Heart-RA-24m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.21e-05 | 174 | 86 | 5 | f04edf2ca6788875c9918611e416fb739924382e | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.33e-05 | 176 | 86 | 5 | 72a2a01618ce836bc843395d5095e9090759b4a6 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.46e-05 | 178 | 86 | 5 | bcbdd45a2307f8aea14122fa0144b96b1f6eec48 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.46e-05 | 178 | 86 | 5 | c413861148129be1ee94f2ceb5999840217eebe5 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Epithelial-Pecam____fenestrated_capillary_endothelial|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.60e-05 | 180 | 86 | 5 | 79c5725f02e038d0187f4a1e1591f2492538aa57 | |
| ToppCell | facs-Kidney-nan-24m-Mesenchymal-kidney_interstitial_fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.67e-05 | 181 | 86 | 5 | c7f5aedcb74c21fb587a95a16d700e2a38a380ee | |
| ToppCell | facs-Kidney-nan-24m-Mesenchymal-kidney_interstitial_fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.67e-05 | 181 | 86 | 5 | 0ec9621a078d004bbd25a587757d24b5cf162959 | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_fibro-stroma-endosteal_fibroblast|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 3.28e-05 | 189 | 86 | 5 | 473b01c9162b12b90a617c600238436177a0d18d | |
| ToppCell | droplet-Trachea-3m-Epithelial-airway_epithelial-neuroendocrine_cell-neuroendocrine|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.45e-05 | 191 | 86 | 5 | 72f1ddc09080dbfea8d51294cbf7f9d4925f9cc0 | |
| ToppCell | droplet-Trachea-3m-Epithelial-airway_epithelial-neuroendocrine_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.45e-05 | 191 | 86 | 5 | 6e7f589efc997f32175e0789c5ea7ca46e1389b8 | |
| ToppCell | droplet-Trachea-nan-3m-Epithelial-neuroendocrine_cell|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.45e-05 | 191 | 86 | 5 | 3ce403e0beedb544edeb3ae6eb30267040d00c21 | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_fibro-stroma|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 3.54e-05 | 192 | 86 | 5 | 4ed5040594ba2d0639f0990697504ecef872ca70 | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_fibro|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 3.54e-05 | 192 | 86 | 5 | d4f5d6653564c2c5d0f5f7c932d89cb1b1412844 | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_fibro-stroma-arteriolar_fibroblast|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 3.62e-05 | 193 | 86 | 5 | 3d85c28f6ebdcb15e875ad01d52d6c138fbf8525 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.90e-05 | 196 | 86 | 5 | 7d8505dac15fa59935ccf592afc54b04c4c6554f | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Mesenchymal-skeletal_muscle_satellite_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.00e-05 | 197 | 86 | 5 | 5bc11aff92da2a0aca8473f997fe7a99f3cae75d | |
| ToppCell | Bronchial_Brush-Epithelial-Basal_1|Bronchial_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 4.00e-05 | 197 | 86 | 5 | f5d87824c0020c95d89e069fd9f70b49e5d5fcea | |
| ToppCell | Bronchial_Brush-Epithelial-Basal_1|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 4.09e-05 | 198 | 86 | 5 | 10a17d7c116dcd6cf847fe6f5d7196d887cad1f9 | |
| ToppCell | proximal-mesenchymal-Alveolar_Fibroblast|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.19e-05 | 199 | 86 | 5 | 7f4840ae6a888380feca722543e5e52783f3e35d | |
| ToppCell | proximal-3-mesenchymal-Alveolar_Fibroblast|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.19e-05 | 199 | 86 | 5 | 301d02bbb37e6f1d24b6e865bc3fe3e91260eb30 | |
| ToppCell | proximal-mesenchymal-Alveolar_Fibroblast-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.19e-05 | 199 | 86 | 5 | 9a16e519fb0651a7c4d8e05b931df4fb3b0eb3d1 | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 4.19e-05 | 199 | 86 | 5 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | TCGA-Bone_and_Soft_Tissue-Primary_Tumor-Sarcoma-Desmoid_Tumor|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9 | 8.36e-05 | 119 | 86 | 4 | d8fbea9ded96fcc3ebdfb4d28873c563427ce811 | |
| ToppCell | TCGA-Bone_and_Soft_Tissue-Primary_Tumor-Sarcoma-Desmoid_Tumor-7|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9 | 8.36e-05 | 119 | 86 | 4 | 9e38f13bf98b9ee44b178300e6f80fd08a006296 | |
| ToppCell | TCGA-Bladder-Solid_Tissue_Normal-Urothelial_normal_tissue-Urothelial_normal_tissue-6|TCGA-Bladder / Sample_Type by Project: Shred V9 | 1.07e-04 | 127 | 86 | 4 | d61b71572eab8a850ee8ce54323fb247525006e5 | |
| Drug | bipy | 9.05e-08 | 97 | 87 | 7 | CID000001474 | |
| Drug | PKI166 | 1.09e-06 | 48 | 87 | 5 | CID006918403 | |
| Drug | hydantoin-5-propionic acid | 1.13e-06 | 21 | 87 | 4 | CID000000782 | |
| Drug | AZFd | 1.67e-06 | 23 | 87 | 4 | CID000196489 | |
| Drug | poly(G | 5.01e-06 | 114 | 87 | 6 | CID000439502 | |
| Drug | Azathymine, 6 [932-53-6]; Down 200; 31.4uM; MCF7; HT_HG-U133A | 1.03e-05 | 196 | 87 | 7 | 2827_DN | |
| Drug | glutamin | TGM1 GSPT2 FMR1 RBMY1A1 POLG DNAJA2 RBMY1D RBMY1B RBMY1E EP300 | 1.04e-05 | 461 | 87 | 10 | CID000000738 |
| Drug | Loracarbef [121961-22-6]; Down 200; 10.8uM; MCF7; HT_HG-U133A | 1.06e-05 | 197 | 87 | 7 | 3532_DN | |
| Drug | Vistar | 1.07e-05 | 36 | 87 | 4 | CID000040896 | |
| Drug | haloperidol; Down 200; 10uM; PC3; HT_HG-U133A | 1.10e-05 | 198 | 87 | 7 | 4468_DN | |
| Drug | 2-chlorodideoxyadenosine | 2.19e-05 | 43 | 87 | 4 | CID000072194 | |
| Drug | HgCl | 3.70e-05 | 49 | 87 | 4 | CID000024182 | |
| Disease | Epilepsy, Cryptogenic | 8.61e-05 | 82 | 83 | 4 | C0086237 | |
| Disease | Awakening Epilepsy | 8.61e-05 | 82 | 83 | 4 | C0751111 | |
| Disease | Aura | 8.61e-05 | 82 | 83 | 4 | C0236018 | |
| Disease | Neurodevelopmental Disorders | 1.40e-04 | 93 | 83 | 4 | C1535926 | |
| Disease | interleukin 9 measurement | 2.44e-04 | 43 | 83 | 3 | EFO_0008192 | |
| Disease | Epilepsy | 2.59e-04 | 109 | 83 | 4 | C0014544 | |
| Disease | Diffuse Large B-Cell Lymphoma | 5.07e-04 | 55 | 83 | 3 | C0079744 | |
| Disease | unipolar depression | KCNG2 FBLN5 INSYN1 KCNG1 CPSF6 DDR2 YLPM1 DGKB DDX21 CLCC1 SLC12A5 | 5.53e-04 | 1206 | 83 | 11 | EFO_0003761 |
| Disease | autosomal dominant polycystic kidney disease (is_marker_for) | 6.96e-04 | 14 | 83 | 2 | DOID:898 (is_marker_for) | |
| Disease | asthma, body mass index | 6.96e-04 | 14 | 83 | 2 | EFO_0004340, MONDO_0004979 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 9.07e-04 | 152 | 83 | 4 | DOID:0060041 (implicated_via_orthology) | |
| Disease | prostate cancer (is_marker_for) | 9.99e-04 | 156 | 83 | 4 | DOID:10283 (is_marker_for) | |
| Disease | Age-related macular degeneration | 1.16e-03 | 18 | 83 | 2 | cv:C0242383 | |
| Disease | late-onset Alzheimers disease | 1.42e-03 | 292 | 83 | 5 | EFO_1001870 | |
| Disease | age of onset of asthma | 1.45e-03 | 79 | 83 | 3 | OBA_2001001 | |
| Disease | macula measurement | 2.02e-03 | 189 | 83 | 4 | EFO_0008375 | |
| Disease | Ischemic stroke, coronary artery disease | 2.25e-03 | 92 | 83 | 3 | EFO_0001645, HP_0002140 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| MRRAGLGEGVPPGNY | 1 | O15155 | |
| EYMNRQRDGGGPGGD | 1261 | P21860 | |
| IGAGRGRQNMQYPNP | 196 | Q09472 | |
| AQQPGPMYTGRERVN | 81 | A8MTB9 | |
| MSGGFELQPRDGGPR | 1 | Q8IW19 | |
| GPGGMVNRDEYLLGR | 76 | Q9NXE8 | |
| YTPFGTGPRNCIGMR | 431 | P20815 | |
| YPIGIQGRTPGAMAG | 641 | Q8NFD5 | |
| PYSRERMQGPGQIQT | 1496 | Q8NFD5 | |
| GRVLPAPMLQYGGRN | 411 | Q9H9G7 | |
| GPREAGGALMSPGRY | 196 | Q8TF44 | |
| GMEGAGGDPYRRPAR | 11 | Q9HA90 | |
| PEPRNGGNYCVGRRM | 586 | P59510 | |
| ALVYGQMNEPPGARA | 266 | P06576 | |
| QGPMSQRRENYGVPP | 181 | P0DJD3 | |
| QGPMSQRRENYGVPP | 181 | A6NDE4 | |
| QGPMSQRRENYGVPP | 181 | P0DJD4 | |
| QGPMSQRRENYGVPP | 181 | P0C7P1 | |
| QGPMSQRRENYGVPP | 181 | A6NEQ0 | |
| QGPMSQRRENYGVPP | 181 | Q15415 | |
| MHLEGRDGRRYPGAP | 1 | Q04671 | |
| GELDPERMGSGIQYG | 181 | P20338 | |
| GELDPERMGSGIQYG | 176 | P61018 | |
| SQSGTYPRGLVQPGM | 786 | Q9H0J4 | |
| VQPGMDQYGLRQPGA | 796 | Q9H0J4 | |
| TRPGAGPDYRLMNGG | 131 | Q2T9L4 | |
| GPVGGPTAEMYLRER | 6 | Q8N6L0 | |
| QGPEEPGPDAMRYSL | 231 | Q96JH8 | |
| QRFAGLPETGRMDPG | 66 | Q9NPA2 | |
| EGMERQYASLPRGGP | 1076 | Q8TEW8 | |
| PGRDEAAPLNPGMYS | 86 | Q00444 | |
| PGGIMPGRYNQEVGQ | 986 | Q14703 | |
| RYPLGMSGGQIPDED | 31 | Q16832 | |
| VPVAMGLGDQRYTAP | 276 | Q8TDU6 | |
| RGRYLPEVMGDGLAN | 421 | P35052 | |
| RVGNGEQGRPYPMTD | 86 | Q86SR1 | |
| NPAARMYGGRTPLGS | 266 | Q15653 | |
| AGYPQGKRMGRGAPV | 96 | Q8IYD1 | |
| MGGGERYNIPAPQSR | 1 | Q9NPJ4 | |
| GYGDMVPRSLPGQVV | 371 | Q9UJ96 | |
| EPGGGAEAQAVRYMP | 1016 | Q14315 | |
| SNPTGMERRYGIPQG | 1201 | P54098 | |
| GYGDMVPRSTPGQVV | 426 | Q9UIX4 | |
| GARSEPPASMGLRYN | 1521 | A7KAX9 | |
| PRGYRSQGVGRPCMD | 5301 | Q96RW7 | |
| RYRAPGEQDGDAMPL | 506 | P25205 | |
| PGCVRVVRGEGMPQY | 306 | O60884 | |
| VVRGEGMPQYRNPFE | 311 | O60884 | |
| YVTDDGQGMGRGSRP | 461 | Q06787 | |
| DGEIRGYLPGTAEMR | 311 | Q9BXC9 | |
| PGRGDSNRRAQYMPK | 101 | A2AJT9 | |
| DRGDYGPPGREMDTA | 391 | Q16630 | |
| MNPGYAGRAELPDNL | 1531 | Q8TD57 | |
| GEMEPEPGYRGDREK | 1626 | Q12873 | |
| MKQRGVGGEVYSQPP | 1436 | Q86UU0 | |
| RQVYSLSGNGPMPGL | 466 | Q9Y6T7 | |
| MPGPAAGSRARVYAE | 1 | P19784 | |
| MSAEYGQRQQPGGRG | 1 | A0A2R8Y619 | |
| GNEGREFYMRQTGPI | 386 | Q9UBX5 | |
| TPYGGQFERMRNGID | 296 | Q9NR30 | |
| GDGPRPPKMARYDNG | 1156 | Q08211 | |
| RLRAEPGYGNMDGAV | 826 | Q9BZF2 | |
| NMPGPPRNRNGDENY | 1096 | Q9H2X9 | |
| GTQPPYGGGTMVVQR | 876 | Q8N4C8 | |
| MAPEIIDQGPRGYGA | 816 | Q6ZN16 | |
| DGYMGPTCREGGPLR | 1496 | O75095 | |
| FMSVQRPGPYDRPGT | 201 | P52597 | |
| RLGGMEYPSVNTGFP | 81 | Q9H0K4 | |
| RDREGPPMDYRGGDG | 126 | P78332 | |
| AMENGTGPYGEERPR | 36 | Q9NXH9 | |
| EMGTPGYRGERINQL | 236 | Q6DKI1 | |
| ANAIPDGPRGYRMIT | 416 | Q9Y2Z4 | |
| AIGDPGRANMPGYNE | 1406 | Q5QGS0 | |
| QGPMPRVRYYAGDER | 36 | Q9H3S1 | |
| NAMPRADGLYRGSPL | 991 | Q9C0A6 | |
| PMTPRYNDGRCLEGG | 2496 | Q9UKZ4 | |
| RRGPEMGYLPGSDRD | 61 | Q6UXD5 | |
| MQGARAPRDQGRSPG | 1 | Q96BI1 | |
| GQGGYPGKPRNRMVR | 841 | Q9BXP5 | |
| GPNYQEGLRVMGEVG | 381 | P53396 | |
| RGQMGPTEQGPYAKT | 401 | Q96S66 | |
| PMLFGGGQERNFRPG | 281 | Q96I15 | |
| PEQMGKDGRGYVPAT | 631 | P42226 | |
| DRPVYEGPSMFGGER | 1771 | P49750 | |
| EAERAAGMGSYVPPR | 101 | O00488 | |
| DRRGMPYGGRGDPVN | 306 | P22735 | |
| RRPGEPFNGQMVTEG | 541 | Q6ZMP0 | |
| GTGGSAMYRPQQPVA | 886 | O94979 | |
| QRQPGSPMYRREGQA | 866 | Q9P275 | |
| MNPGRRGIRIYGDED | 21 | Q5T124 | |
| PRSPANGDYRDTGMV | 541 | Q6UXF1 | |
| GNGTGEARDMYVPNP | 576 | Q5T447 |